DEFA14A ·Filed Apr 23, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any unexpected developments in the upcoming shareholder meeting, though this filing suggests business as usual.
Final — all horizons settled through T+60d ⚠ clustered
DYN ▲ +30.50% at T+60d
NEUTRAL call ✓ call won +30.50% · α vs SPY +25.42% · entry $18.26 → $23.83
T+1d
-1.20%
call -1.20% · α -1.37%
$18.04
settled 5mo ago
T+5d
-3.89%
call -3.89% · α -4.80%
$17.55
settled 5mo ago
T+20d
-4.87%
call -4.87% · α -8.90%
$17.37
settled 4mo ago
T+60d
+30.50%
call +30.50% · α +25.42%
$23.83
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Dyne Therapeutics has filed its definitive proxy statement for the upcoming annual shareholder meeting. The filing is routine and contains no material changes or unexpected events. The company is seeking shareholder approval for director elections, executive compensation, and auditor appointment.
Key Facts
- Routine proxy filing for annual shareholder meeting
- No material changes or unexpected events disclosed
- Items include director elections, executive compensation, and auditor appointment
Financial Impact
No immediate financial impact expected
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-173702 |
| Document: 0001193125-26-173702-index-headers.html | 0001193125-26-173702 |
| Document: 0001193125-26-173702-index.html | 0001193125-26-173702 |
| Document: 0001193125-26-173702.txt | 0001193125-26-173702 |
44 reports for DYN
87% Hit rate best @ T+60▲ +46.36%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
Showing 10 of 44
US Market Status
Market Closed — Opens Mon (65h 4m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access